Citations (29)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Dieudonné Buh Kum, Robbert Boudewijns, Ji Ma, Niraj Mishra, Dominique Schols, Johan Neyts & Kai Dallmeier. (2020) A chimeric yellow fever-Zika virus vaccine candidate fully protects against yellow fever virus infection in mice. Emerging Microbes & Infections 9:1, pages 520-533.
Read now
Read now
Nagendra R. Hegde & Milind M. Gore. (2017) Japanese encephalitis vaccines: Immunogenicity, protective efficacy, effectiveness, and impact on the burden of disease. Human Vaccines & Immunotherapeutics 13:6, pages 1320-1337.
Read now
Read now
K Chokephaibulkit, G Houillon, E Feroldi & A Bouckenooghe. (2016) Safety and immunogenicity of a live attenuated Japanese encephalitis chimeric virus vaccine (IMOJEV®) in children. Expert Review of Vaccines 15:2, pages 153-166.
Read now
Read now
Xing Li, Shu-Juan Ma, Xie Liu, Li-Na Jiang, Jun-Hua Zhou, Yi-Quan Xiong, Hong Ding & Qing Chen. (2014) Immunogenicity and safety of currently available Japanese encephalitis vaccines: A systematic review. Human Vaccines & Immunotherapeutics 10:12, pages 3579-3593.
Read now
Read now
Sang-Im Yun & Young-Min Lee. (2014) Japanese encephalitis. Human Vaccines & Immunotherapeutics 10:2, pages 263-279.
Read now
Read now
Pascale Cottin, Matthias Niedrig & Cristina Domingo. (2013) Safety profile of the yellow fever vaccine Stamaril®: a 17-year review. Expert Review of Vaccines 12:11, pages 1351-1368.
Read now
Read now
Mohan Babu Appaiahgari & Sudhanshu Vrati. (2012) Clinical development of IMOJEV®—a recombinant Japanese encephalitis chimeric vaccine (JE-CV). Expert Opinion on Biological Therapy 12:9, pages 1251-1263.
Read now
Read now
Scott B Halstead & Stephen J Thomas. (2011) New Japanese encephalitis vaccines: alternatives to production in mouse brain. Expert Review of Vaccines 10:3, pages 355-364.
Read now
Read now
Articles from other publishers (21)
Luis Furuya-Kanamori, Narayan Gyawali, Deborah J Mills, Christine Mills, Leon E Hugo, Gregor J Devine & Colleen L Lau. (2023) Immunogenicity of a single fractional intradermal dose of Japanese encephalitis live attenuated chimeric vaccine. Journal of Travel Medicine 30:2.
Crossref
Crossref
J Xiang, Q Chang, J H McLinden, N Bhattarai, J L Welch, T M Kaufman & Jack T Stapleton. (2023) Characterization of “Off-Target” Immune Modulation Induced by Live Attenuated Yellow Fever Vaccine. The Journal of Infectious Diseases.
Crossref
Crossref
Francieli Fontana Sutile Tardetti Fantinato, Virginia Kagure Wachira, Victor Bertollo Gomes Porto, Henry Maia Peixoto & Elisabeth Carmen Duarte. (2023) Factors associated with yellow fever vaccine failure: A systematic literature review. Vaccine 41:13, pages 2155-2169.
Crossref
Crossref
John Tyler Sandberg, Marie Löfling, Renata Varnaitė, Johanna Emgård, Nabil Al-Tawil, Lars Lindquist, Sara Gredmark-Russ, Jonas Klingström, Karin Loré, Kim Blom & Hans-Gustaf Ljunggren. (2023) Safety and immunogenicity following co-administration of Yellow fever vaccine with Tick-borne encephalitis or Japanese encephalitis vaccines: Results from an open label, non-randomized clinical trial. PLOS Neglected Tropical Diseases 17:2, pages e0010616.
Crossref
Crossref
J. Erin Staples, Emily H. Davis, Thomas P. Monath & Alan D.T. Barrett. 2023. Plotkin's Vaccines. Plotkin's Vaccines
1251
1321.e19
.
Scott B. Halstead, Susan L. Hills, Anthony A. Marfin & Tom Solomon. 2023. Plotkin's Vaccines. Plotkin's Vaccines
577
607.e11
.
Kerstin Kling, Cristina Domingo, Christian Bogdan, Steven Duffy, Thomas Harder, Jeremy Howick, Jos Kleijnen, Kevin McDermott, Ole Wichmann, Annelies Wilder-Smith & Robert Wolff. (2022) Duration of Protection After Vaccination Against Yellow Fever: A Systematic Review and Meta-Analysis. Clinical Infectious Diseases 75:12, pages 2266-2274.
Crossref
Crossref
Michael E. Wechsler, Adelmir Souza-Machado, Christine Xu, Xuezhou Mao, Upender Kapoor, Faisal A. Khokhar, John T. O’Malley, Christopher D. Petro, Veronica Mas Casullo, Leda P. Mannent, Paul J. Rowe, Juby A. Jacob-Nara, Marcella Ruddy, Elizabeth Laws, Lisa A. Purcell & Megan Hardin. (2022) Preclinical and clinical experience with dupilumab on the correlates of live attenuated vaccines. Journal of Allergy and Clinical Immunology: Global 1:1, pages 9-15.
Crossref
Crossref
Luis Furuya-Kanamori, Chang Xu, Suhail A.R. Doi, Justin Clark, Kinley Wangdi, Deborah J. Mills & Colleen L. Lau. (2021) Comparison of immunogenicity and safety of licensed Japanese encephalitis vaccines: A systematic review and network meta-analysis. Vaccine 39:32, pages 4429-4436.
Crossref
Crossref
Petra Zimmermann, Andrew J Pollard & Nigel Curtis. (2020) What time interval is needed between the administration of live attenuated vaccines?. Archives of Disease in Childhood 105:12, pages 1232-1235.
Crossref
Crossref
Niraj Mishra, Robbert Boudewijns, Michael Alexander Schmid, Rafael Elias Marques, Sapna Sharma, Johan Neyts & Kai Dallmeier. (2020) A Chimeric Japanese Encephalitis Vaccine Protects against Lethal Yellow Fever Virus Infection without Inducing Neutralizing Antibodies. mBio 11:2.
Crossref
Crossref
Bruno Guy, Eng Eong Ooi, Jose Ramos-Castañeda & Stephen J. Thomas. (2020) When Can One Vaccinate with a Live Vaccine after Wild-Type Dengue Infection?. Vaccines 8:2, pages 174.
Crossref
Crossref
Petra Zimmermann & Nigel Curtis. (2019) Factors That Influence the Immune Response to Vaccination. Clinical Microbiology Reviews 32:2.
Crossref
Crossref
Anju Aggarwal & Neha Garg. (2017) Newer Vaccines against Mosquito-borne Diseases. The Indian Journal of Pediatrics 85:2, pages 117-123.
Crossref
Crossref
Thiem Dinh Vu, Quang Dang Nguyen, Huong Thi Ai Tran, Valérie Bosch-Castells, Céline Zocchetti & Guy Houillon. (2018) Immunogenicity and safety of a single dose of a live attenuated Japanese encephalitis chimeric virus vaccine in Vietnam: A single-arm, single-center study. International Journal of Infectious Diseases 66, pages 137-142.
Crossref
Crossref
J. Erin Staples, Thomas P. Monath, Mark D. Gershman & Alan D.T. Barrett. 2018. Plotkin's Vaccines. Plotkin's Vaccines
1181
1265.e20
.
James H McLinden, Nirjal Bhattarai, Jack T Stapleton, Qing Chang, Thomas M Kaufman, Suzanne L Cassel, Fayyaz S Sutterwala, Hillel Haim, Jon C Houtman & Jinhua Xiang. (2017) Yellow Fever Virus, but Not Zika Virus or Dengue Virus, Inhibits T-Cell Receptor–Mediated T-Cell Function by an RNA-Based Mechanism. The Journal of Infectious Diseases 216:9, pages 1164-1175.
Crossref
Crossref
Martin Alberer, Gerd Burchard, Tomas Jelinek, Emil Reisinger, Jiri Beran, Lucie Cerna Hlavata, Eduardo Forleo‐Neto, Alemnew F. Dagnew & Ashwani K. Arora. (2015) Safety and Immunogenicity of Typhoid Fever and Yellow Fever Vaccines When Administered Concomitantly With Quadrivalent Meningococcal ACWY Glycoconjugate Vaccine in Healthy Adults. Journal of Travel Medicine 22:1, pages 48-56.
Crossref
Crossref
Dennis W. Trent, Philip Minor, Teeranart Jivapaisarnpong & Jinho Shin. (2013) WHO working group on the quality, safety and efficacy of Japanese encephalitis vaccines (live attenuated) for human use, Bangkok, Thailand, 21–23 February 2012. Biologicals 41:6, pages 450-457.
Crossref
Crossref
Jean Lang, Lucia F. Bricks & Giovanini Coelho. (2012) Q&A session 06 October 2011: I International Symposium on Dengue, FMUSP, S?o Paulo. Revista do Instituto de Medicina Tropical de S?o Paulo 54:suppl 18, pages 28-30.
Crossref
Crossref
Kristina M. Bacon, Bruce Y. Lee, Derek A. T. Cummings, Rachel R. Bailey, Donald S. Burke, Mirat Shah, Diana L. Connor, Shawn T. Brown, Sarah B. Kitchen & Yongjua Laosiritaworn. (2011) Economic Value of Dengue Vaccine in Thailand. The American Journal of Tropical Medicine and Hygiene 84:5, pages 764-772.
Crossref
Crossref